"NOMIS is all about enabling outstanding talent to take on high-risk research."
- Georg Heinrich “Heini” Thyssen, NOMIS Founder

Ronald Evans honored with Japan Prize

NOMIS Awardee and Salk Professor Ronald Evans has been named the 2024 recipient of the Japan Prize in the field of Medical Science and Pharmaceutical Science. The Japan Prize Foundation awards […]

Can this fish help stop aging?

NOMIS Awardee Anne Brunet’s groundbreaking research into aging was featured in an article in Switzerland’s Tagesanzeiger. Brunet and her lab have pioneered the naturally short-lived African killifish as a promising […]

Deep insights

The work of NOMIS researcher Martin Pilhofer, who holds the NOMIS-supported Professorship of Cryo-Electron Microscopy at ETH Zurich, was profiled in an article in Uplift, an ETH Foundation magazine. Pilhofer’s […]

NOMIS Award: Creating new sparks in science

The NOMIS Distinguished Scientist and Scholar Award is the topic of a recently published advertorial in Science. The 2023 NOMIS Awardees, Anne Brunet and David Autor, explain how the NOMIS […]

Peripheral visual information affects choice

NOMIS Awardee Antonio Rangel and colleagues have shown that peripheral visual information is crucial in facilitating good decisions and suggest that individuals might be influenceable by settings in which only […]

Trailblazing scientists presented with 2023 NOMIS Award

The NOMIS Distinguished Scientist and Scholar Award, which recognizes pioneering researchers for their exceptional contributions to science, was presented to David Autor of MIT and Anne Brunet of Stanford University […]

Origins Federation – A gathering of minds

Researchers from the Centre for Origin and Prevalence of Life at ETH Zurich, including NOMIS–ETH Fellow Craig Walton, emerge from the inaugural conference of the Origins Federation with insightful perspectives […]

Neurodegeneration enters the era of functional genomics

NOMIS Awardee Adriano Aguzzi and colleague Martin Kampmann have published a review article in Science exploring progress in treatment for neurodegenerative diseases. They ask the question, “What accounts for the […]